Radiotherapy remains a key component of modern multimodal anticancer treatment approaches. Although most clinically relevant improvements in radiation oncology are based on optimized radiation technology, it now becomes obvious that biology-based approaches will further boost the efficacy of modern radiation oncology. Of relevance to this is the question of the ultimate fate of an irradiated cell and the mechanistic basis of the induced cell death or inactivation observed. Research bearing on this question is reported in this issue of Oncogene by Wendt et al. (2005) , who show that the levels of p21 CIP/WAF1 play a key role in determining whether an irradiated tumour cell is arrested in the G2 phase of the cell cycle, rather than apoptosing. The demonstration that caffeine treatment can abrogate this G2 arrest, and that the cells go on to die, has implications for overcoming treatment resistance imposed by radiation-induced upregulation of p21 
Radiotherapy remains a key component of modern multimodal anticancer treatment approaches. Although most clinically relevant improvements in radiation oncology are based on optimized radiation technology, it now becomes obvious that biology-based approaches will further boost the efficacy of modern radiation oncology. Of relevance to this is the question of the ultimate fate of an irradiated cell and the mechanistic basis of the induced cell death or inactivation observed. Research bearing on this question is reported in this issue of Oncogene by Wendt et al. (2005) , who show that the levels of p21 CIP/WAF1 play a key role in determining whether an irradiated tumour cell is arrested in the G2 phase of the cell cycle, rather than apoptosing. The demonstration that caffeine treatment can abrogate this G2 arrest, and that the cells go on to die, has implications for overcoming treatment resistance imposed by radiation-induced upregulation of p21 ; cell death Several molecular mechanisms are known to mediate the inactivation of clonogenic tumor cells after irradiation: tumor cells may be inactivated by cell cycle arrest or senescence; they may undergo apoptosis or succumb to related forms of programmed cell death; they may be triggered to undergo differentiation or they may die following mitotic catastrophe. However, the individual contribution of each death modality, and the interrelationship of cell death modalities to the final eradication of clonogenic tumor cells, remains unclear. Although many aspects of the initial response to DNA damage via p53 and other DNA damage checkpoint responses have been analysed in detail (El-Deiry, 2003; Iliakis et al., 2003; Belka et al., 2004) , the balance between death and cell cycle arrest is not yet fully elucidated.
In this issue of Oncogene, J Wendt and co-workers analyse the response of breast cancer cells to ionizing radiation. They employed p53-competent MCF-7 breast cancer cells, making use of a unique characteristic of these cells. Since normal MCF7 cells lack functional caspase-3 due to a genetic deletion, the execution of apoptosis does not take place in these cells even after applying adequate stimuli including epirubicin. After transfection and re-expression of caspase-3, however, the cells again undergo apoptosis when treated with the cytostatic drug doxorubicin. Thus in this experimental setting, the lack of the executor caspase-3 was clearly associated with resistance against a clinically relevant DNA-damaging death trigger. Although the death pathways of doxorubicin are quite similar to those triggered by ionizing radiation, MCF-7 cells expressing caspase-3 do not undergo apoptosis in response to ionizing radiation. After applying ionizing radiation over a relatively wide range of dose, a dose-dependent G2 arrest was the key response elicited.
In a subsequent set of experiments, the authors tested how a pharmacologically triggered release from the G2 arrest, achieved by inhibiting the ATM/ATR kinase, would affect the behavior of the cells. The treatment of the cells with caffeine allowed the induction of apoptosis in caspase-3-expressing cells but not the caspase-3-negative MCF-7 counterparts. In further experiments the authors provided evidence that the effect of caffeine on the G2 arrest was mediated via inhibition of the cell cycle regulator p21 CIP/WAF1 . The increase of the p21 CIP/WAF1 level after irradiation was not observed in cell pretreated with caffeine. In order to prove a functional relationship between the p21 CIP/WAF1 , G2 arrest and apoptosis sensitivity, the authors expressed p21 CIP/WAF1 using an adenoviral expression system. In keeping with the prior experiments, overexpression of p21 abrogated the effects of caffeine on apoptosis sensitivity.
After performing most of the crucial experiments using the MCF-7 breast cancer model, complementary tests were performed using HCT-166 colon carcinoma cells. In contrast to MCF-7 cells, HCT-116 cells undergo caspase-3-dependent, radiation-induced apoptosis without other intervention, at least to a certain extent. Based on the results obtained with the MCF-7, the authors tested how far the absence of a functional G2 block would alter the ability of HCT-116 cells to undergo apoptosis. In this regard, HCT-116 cells lacking the crucial regulator p21 CIP/WAF1 were irradiated and the resulting rates of apoptosis induction were compared with normal control cells. In accordance with the MCF-7 data where the G2 arrest was abrogated by caffeine, apoptosis rates were significantly increased by the lack of p21 CIP/WAF1 . Thus the data prove that p21-mediated cell cycle arrest prevents cells from undergoing apoptosis.
These findings are in accordance with several other observations. In an attempt to analyse which molecular switch decides whether p53 mediates cell cycle arrest or direct apoptosis, Seoane et al. (2002) found that the level of myc directs p53-driven signaling from apoptosis induction to p21 cell cycle arrest via an MIZ-1-mediated inhibition of the p53-driven transcription of p21 CIP/WAF1 . The findings by Wendt et al. (2005) extend this knowledge since they show that even after an initial decision in favor of G2 arrest rather than apoptosis has been made, a parallel option of apoptosis persists, and the initial decision can be reversed by forced release of the cells from the radiation-induced G2 arrest.
In terms of our general view regarding the radiationinduced inactivation of clonogenic tumor cells, the findings point to a very complex network of steps. As introduced above, four important mechanisms can participate in inactivation of clonogenic tumor cells after irradiation: (1) cell cycle arrest, (2) direct induction of apoptosis or related forms of programmed cell death, (3) mitotic catastrophe, and (4) terminal differentiation. These processes are frequently interpreted to be distinct pathways; however, current data clearly allow the interpretation that most, if not all, of the given pathways are closely linked. In the case of cell cycle arrest and apoptosis, the data presented by Wendt et al. show that a G2 arrest or the induction of apoptosis are two parallel processes directed by the level of p21 CIP/WAF1 in a given situation. Thus, if the apoptotic machinery is intact and the level of p21 CIP/WAF1 does not reach a critical level, the irradiated cells are directly removed by apoptosis. Alternatively, the cells are arrested in G2 and then either persist in a state of terminal G2 arrest, or escape this state to die by apoptosis, or recover completely (Figure 1) .
Other forms of cell death are less well understood on a molecular level. However, mitotic catastrophe is considered to be one of the most important death modalities after ionizing radiation, and some of its mechanistic aspects have been revealed very recently: In this regard, data provided by G Kroemer's group suggest that mitotic catastrophe results when DNA damage takes place in cells with an inhibited Chk2 function, and that death by this pathway requires caspase-2 and cytochrome c release. Thus from a mechanistic standpoint, mitotic catastrophe is a special subtype of a caspasemediated death modality (Castedo et al., 2004a, b) .
The question of how far the findings reported by Wendt et al. mirror the clinical situation, and whether apoptosis is a similarly parallel option to cell cycle arrest for tumor cells in patients undergoing radiation therapy, is not completely solved. However, there are several well-documented pieces of evidence showing that the balance between G2 arrest and apoptosis induction determine clinical outcomes. Following a dynamic expression profile of p21 CIP/WAF1 and Bax after neoadjuvant radiochemotherapy for colorectal cancer, the decline of p21 CIP/WAF1 and an increase in proliferation was associated with an improved response to the treatment (Rau et al., 2003) . A second set of data pointing to a mutual role of cell cycle control and apoptosis on the therapeutic outcome showed that the lack of p16(ink4a/CDKN2) and the parallel lack of bax were predictors of a negative outcome in patients with esophageal cancer (Sturm et al., 2001) .
Taken together, all data suggest that radiationinduced outcomes, in terms of both in vitro and in vivo end points, seem to be influenced by a complex molecular interplay between different cell death modalities, inactivation pathways or even pathways of recovery. All available data make it highly unlikely that a single death modality determines the outcome of radiation therapy. Thus in vitro research as well as translational research accompanying early clinical trials have to take into account that a wide variety of different modalities of cell death induction and eradication of clonogenic tumor cells exist.
The encouraging feature of the study by Wendt et al. is the demonstration that this interplay can be manipulated to therapeutic advantage. Thus cells that initially respond to radiation by entering a state (G2 arrest) where recovery remains a possibility have nonetheless been primed for a parallel pathway of cell death, onto which they can be rerouted and thereby eradicated. expression, cells are arrested in G2 whereas blockage of p21 directly leads to apoptosis. The specific molecular switches from DNA damage to differentiation or mitotic catastrophe remain to be fully elucidated.
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